Target Name: NPIPB7
NCBI ID: G440350
Review Report on NPIPB7 Target / Biomarker Content of Review Report on NPIPB7 Target / Biomarker
NPIPB7
Other Name(s): A-761H5.5 | nuclear pore complex-interacting protein-like 1 | A-575C2.4 | Nuclear pore complex interacting protein family member B7 | Nuclear pore complex interacting protein-like 1 | nuclear pore complex interacting protein family member B7 | NPIPL1

Understanding NPIPB7: A Potential Drug Target and Biomarker

NPIPB7 (N-acetyl-p-valine N-acetyltransferase 7) is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and muscle. It is a member of the family of transmembrane proteins, which means that it spans the cell membrane and is associated with various cellular processes.

One of the unique features of NPIPB7 is its role in the production of a type of acetyl groups, which are often found on proteins and other biomolecules. These acetyl groups play a critical role in the regulation of protein function and are involved in many cellular processes, including cell signaling, protein stability, and metabolism.

In addition to its role in protein synthesis and regulation, NPIPB7 is also known for its potential as a drug target. Its unique structure and the various functions that it is involved in have make it an attractive target for researchers to study and potentially develop new treatments for a variety of diseases.

One of the reasons why NPIPB7 is a promising drug target is its location in the brain. The brain is a complex and dynamic system that is involved in many important cognitive and behavioral functions, and it is home to many of the body's chemical and electrical signals. As a result, drugs that can modulate the activity of NPIPB7 in the brain have the potential to treat a wide range of conditions, including neurological and psychiatric disorders.

In addition to its potential as a drug target, NPIPB7 is also a biomarker that can be used to diagnose and monitor a variety of diseases. Its expression has been detected in a variety of tissues and has been associated with a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the challenges in studying NPIPB7 as a drug target is its complexity. Its structure and function are not well fully understood, and there is currently a lack of effective techniques for its production and study. However, researchers are making progress in understanding its role in the brain and its potential as a drug target.

In addition to its potential as a drug target and biomarker, NPIPB7 is also of interest to researchers because of its unique structure and the many different ways that it can be modified. This makes it an attractive target for researchers who are looking for new and innovative ways to treat a variety of diseases.

Overall, NPIPB7 is a protein that is of great interest to researchers due to its unique structure and the various functions that it is involved in. Its potential as a drug target and biomarker make it an attractive target for researchers who are looking for new and innovative ways to treat a variety of diseases.

Protein Name: Nuclear Pore Complex Interacting Protein Family Member B7

The "NPIPB7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NPIPB7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NPIPB8 | NPIPB9 | NPIPP1 | NPL | NPLOC4 | NPM1 | NPM1P13 | NPM1P21 | NPM1P22 | NPM1P25 | NPM1P27 | NPM1P28 | NPM1P35 | NPM1P42 | NPM1P47 | NPM1P48 | NPM2 | NPM3 | NPNT | NPPA | NPPA-AS1 | NPPB | NPPC | NPR1 | NPR2 | NPR3 | NPRL2 | NPRL3 | NPS | NPSR1 | NPSR1-AS1 | NPTN | NPTN-IT1 | NPTX1 | NPTX2 | NPTXR | NPVF | NPW | NPY | NPY1R | NPY2R | NPY4R | NPY4R2 | NPY5R | NPY6R | NQO1 | NQO2 | NR0B1 | NR0B2 | NR1D1 | NR1D2 | NR1H2 | NR1H3 | NR1H4 | NR1I2 | NR1I3 | NR2C1 | NR2C2 | NR2C2AP | NR2E1 | NR2E3 | NR2F1 | NR2F1-AS1 | NR2F2 | NR2F2-AS1 | NR2F6 | NR3C1 | NR3C2 | NR4A1 | NR4A2 | NR4A3 | NR5A1 | NR5A2 | NR6A1 | NRAD1 | NRADDP | NRAP | NRARP | NRAS | NRAV | NRBF2 | NRBF2P4 | NRBP1 | NRBP2 | NRCAM | NRDC | NRDE2 | NREP | NRF1 | NRG1 | NRG2 | NRG3 | NRG4 | NRGN | NRIP1 | NRIP2 | NRIP3 | NRIP3-DT | NRIR | NRK